Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

The focus will initially be on creating computational and digital pathology products, as well as AI-assisted algorithms.

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

Matthew Herper covers medical innovation — both its promise and its perils. A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap ...

While AstraZeneca had said the price negotiations would impact its ability to make research and development decisions, it failed to give an example of how that impact had materialized, the court said.

"[Friday’s] announcement is a strong testament to AstraZeneca's commitment to biopharmaceutical research and development in Quebec and Canada. Through the creation of the N?OMED ...

The Immunotherapy Drugs Market is set to grow from USD 257.60 billion in 2024 to USD 486.36 billion by 2030, with a CAGR of ...

AstraZeneca continues to lead development and Amgen continues to lead manufacturing. All aspects of the collaboration are under the oversight of joint governing bodies. Under the amended agreement, ...

Danaher Corporation DHR recently partnered with AstraZeneca PLC AZN to develop and market novel diagnostic tools aimed at ...

From surgical precision tools to real-time diagnostics, brain-responsive stimulation, and multi-disease detection systems, AI ...

AstraZeneca has teamed up with DNA sequencing ... and protein expression. The research collaboration will explore the use of the two companies' technologies side by side to find targets across ...